Newer disease modifying treatments in pediatric onset multiple sclerosis: experience from a single center

I Solmaz, PA Ozen, S Parlak, A Tuncer… - European Journal of …, 2022 - Elsevier
Abstract Background Disease modifying treatments (DMTs) for multiple sclerosis include
injectable drugs (iDMTs) like interferons (IFNs) or glatiramer acetate (GA), and newer agents …
被引用次数：4 相关文章

Newer disease modifying treatments in pediatric onset multiple sclerosis: Experience from a single center.

I Solmaz, S Parlak, A Tuncer, B Anlar - European Journal of …, 2022 - europepmc.org
Background Disease modifying treatments (DMTs) for multiple sclerosis include injectable
drugs (iDMTs) like interferons (IFNs) or glatiramer acetate (GA), and newer agents (nDMTs) …

Newer disease modifying treatments in pediatric onset multiple sclerosis: Experience from a single center

I Solmaz, PA Ozen, S Parlak… - European journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Disease modifying treatments (DMTs) for multiple sclerosis include injectable
drugs (iDMTs) like interferons (IFNs) or glatiramer acetate (GA), and newer agents (nDMTs) …

Newer disease modifying treatments in pediatric onset multiple sclerosis: Experience from a single center

I Solmaz, PA Ozen, S Parlak, A Tuncer… - European Journal of …, 2022 - ejpn-journal.com
Abstract Background Disease modifying treatments (DMTs) for multiple sclerosis include
injectable drugs (iDMTs) like interferons (IFNs) or glatiramer acetate (GA), and newer agents …

Newer disease modifying treatments in pediatric onset multiple sclerosis: Experience from a single center

İ SOLMAZ, P Ozen, Ş Parlak… - EUROPEAN …, 2022 - avesis.hacettepe.edu.tr
Background: Disease modifying treatments (DMTs) for multiple sclerosis include injectable
drugs (iDMTs) like interferons (IFNs) or glatiramer acetate (GA), and newer agents (nDMTs) …